Document Detail


Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers.
MedLine Citation:
PMID:  7669259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Studies have demonstrated greater hazards associated with anaphylaxis in patients receiving beta-blockers. Serious anaphylaxis is more frequent. Evidence suggests this occurs via modulation of adenylate cyclase, which can influence release of anaphylactogenic mediators. Treatment of anaphylaxis in patients exposed to beta-blockers is complicated because therapeutic administration of epinephrine (adrenaline) may be ineffective or promote undesired alpha-adrenergic and vagotonic effects. Risk reduction efforts should be considered for patients receiving beta-blockers who are prone to experience anaphylaxis.
Authors:
D M Lang
Related Documents :
7365189 - A system for rating the severity of senility.
14524599 - Reversal of heart failure remodeling: is it maintained?
2689729 - Enzyme immunoassay (elisa) for the detection of anticarbohydrate antibodies in rheumati...
21556789 - Echocardiographic evidence of pulmonary hypertension is associated with increased 1-yea...
10841219 - The use of subcutaneous erythropoietin and intravenous iron for the treatment of the an...
18701919 - The prevalence of erectile dysfunction in heart failure patients by race and ethnicity.
14738149 - Anti-cd20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
24375669 - Nizatidine ameliorates gastroparesis in parkinson's disease: a pilot study.
10210879 - Association between deficiency of free protein s and anticardiolipin antibodies in pati...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug safety : an international journal of medical toxicology and drug experience     Volume:  12     ISSN:  0114-5916     ISO Abbreviation:  Drug Saf     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-10-19     Completed Date:  1995-10-19     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9002928     Medline TA:  Drug Saf     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  299-304     Citation Subset:  IM    
Affiliation:
Department of Medicine, Hahnemann University Hospital, Philadelphia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / adverse effects*,  pharmacokinetics
Anaphylaxis / chemically induced*
Humans
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of cholesterol side-chain cleavage cytochrome P450 in mouse testis Leydig cell line I-10.
Next Document:  Adverse effects of monobactams and carbapenems.